Literature DB >> 16670811

[Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy].

G Ruiz-Irastorza1, M A Khamashta.   

Abstract

Women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are subject to several complications during pregnancy, including reactivation of SLE, thrombosis, miscarriage, neonatal lupus, pregnancy-induced hypertension, pulmonary hypertension and drug toxicity. Correct management of these patients requires combined medical-obstetric care, close surveillance of baby's growth and well-being, control of SLE activity and correct thromboprophylaxis. With good care, most pregnancies in women with SLE and APS end successfully.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670811     DOI: 10.1007/s00393-006-0058-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  43 in total

1.  Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants.

Authors:  O Baud; L Foix-L'Helias; M Kaminski; F Audibert; P H Jarreau; E Papiernik; C Huon; J Lepercq; M Dehan; T Lacaze-Masmonteil
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Assessing disease activity in SLE patients during pregnancy.

Authors:  J P Buyon; K C Kalunian; R Ramsey-Goldman; M A Petri; M D Lockshin; G Ruiz-Irastorza; M Khamashta
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 3.  Treatment of pregnancy loss in Hughes syndrome: a critical update.

Authors:  Guillermo Ruiz-Irastorza; Munther A Khamashta; Graham R V Hughes
Journal:  Autoimmun Rev       Date:  2002-10       Impact factor: 9.754

4.  Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.

Authors:  F Carmona; J Font; M Azulay; M Creus; F Fábregues; R Cervera; B Puerto; J Balasch
Journal:  Am J Reprod Immunol       Date:  2001-10       Impact factor: 3.886

Review 5.  Antiphospholipid antibodies in healthy pregnant women.

Authors:  A Lynch; R Silver; W Emlen
Journal:  Rheum Dis Clin North Am       Date:  1997-02       Impact factor: 2.670

6.  Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.

Authors:  R K Silver; S N MacGregor; J S Sholl; J M Hobart; M G Neerhof; A Ragin
Journal:  Am J Obstet Gynecol       Date:  1993-12       Impact factor: 8.661

7.  Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases.

Authors:  Francisco Carmona; Josep Font; Isabel Moga; Isabel Làzaro; Ricard Cervera; Visitación Pac; Juan Balasch
Journal:  Am J Reprod Immunol       Date:  2005-04       Impact factor: 3.886

8.  Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

Authors:  R Rai; H Cohen; M Dave; L Regan
Journal:  BMJ       Date:  1997-01-25

Review 9.  Antiphospholipid syndrome: obstetric diagnosis, management, and controversies.

Authors:  D Ware Branch; Munther A Khamashta
Journal:  Obstet Gynecol       Date:  2003-06       Impact factor: 7.661

10.  Underlying disorders associated with severe early-onset preeclampsia.

Authors:  G A Dekker; J I de Vries; P M Doelitzsch; P C Huijgens; B M von Blomberg; C Jakobs; H P van Geijn
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

View more
  1 in total

Review 1.  Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?

Authors:  Adel Abu-Heija
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.